Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Editorial

Advances in Inhalation Drug Delivery

Author(s): Philip Chi Lip Kwok

Volume 27, Issue 12, 2021

Published on: 21 April, 2021

Page: [1435 - 1435] Pages: 1

DOI: 10.2174/138161282712210421084343

Next »
[1]
Chen J, Martin A, Finlay WH. Recent In Vitro and In Silico Advances in the Understanding of Intranasal Drug Delivery. Curr Pharm Des 2021; 27(12): 1482-97.
[2]
Liang Y, Mak JCW. Inhaled Therapies for Asthma and Chronic Obstructive Pulmonary Disease. Curr Pharm Des 2021; 27(12): 1496-81.
[3]
Rossi I, Bettini R, Buttini F. Resistant Tuberculosis: the Latest Advancements of Second-line Antibiotic Inhalation Products. Curr Pharm Des 2021; 27(12): 1436-52.
[4]
Liao Q, Lam JKW. Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses. Curr Pharm Des 2021; 27(12): 1453-68.

© 2024 Bentham Science Publishers | Privacy Policy